Patients who seek breast reconstruction, revision or secondary breast augmentation, or a first time breast enlargement may enroll in the trial. A list of prohibited medical conditions for participating in the study must be satisfied, and patients must agree to a ten-year follow-up.
Jacob Gerzenshtein, MD, FACS,
A Board Certified Plastic Surgeon
